Browse COVID-19 resources from partners and CCSA experts – trusted sources for your information and research needs.

Canadian Centre on Substance Use and Addiction

The information on COVID-19 and substance use in this section focuses on activities and procedures that people and service providers might consider once measures to contain the virus, such as physical distancing, are relaxed. Resources are classified according to their focus on Resuming Activities, Substances, Harm Reduction and Treatment, Policies and Guides, and Academic Publications.

CCSA cannot vouch for the accuracy or currency of the information in these resources. Inclusion of a resource on this page does not imply endorsement or authorization by CCSA.

Academic Publication

Academic Publication

Resource Organization
Mitigating and learning from the impact of COVID-19 infection on addictive disorders Addiction
COVID-19 and people who use drugs: a call for action Canadian Journal of Public Health
Public health policies can reduce inequalities as we come out of lockdown BMJ
COVID ‐19 and alcohol in Australia: Industry changes and public health impacts Drug and Alcohol Review
COVID-19 - Enacting a ‘new normal’ for people who use drugs International Journal of Drug Policy
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption JAMA Psychiatry
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond Journal of Addiction Medicine

 

Harm Reduction & Treatment

Harm Reduction & Treatment

Resource Organization
World Drug Report 2020: Executive Summary Impact of COVID-19 EurekALERT
EMCDDA trendspotter briefing - May 2020 - Impact of COVID-19 on drug services and help-seeking in Europe European Monitoring Centre for Drugs and Drug Addiction
Telehealth Must Stay After COVID-19 to Save Our Patients From Overdose Filter Magazine
COVID-19 - Enacting a ‘new normal’ for people who use drugs International Journal of Drug Policy
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption JAMA Psychiatry
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond Journal of Addiction Medicine
Supervised Dispensing after COVID-19 National Health Service Substance Misuse Provider Alliance
With You through COVID-19: crisis and recovery We Are With You

 

Resuming Activities

Resuming Activities

Resource Organization
Getting Back on the Road Impaired Driving Risks (Infographic) Canadian Centre on Substance Use and Addiction
EMCDDA trendspotter briefing - May 2020 - Impact of COVID-19 on drug services and help-seeking in Europe European Monitoring Centre for Drugs and Drug Addiction
Telehealth Must Stay After COVID-19 to Save Our Patients From Overdose Filter Magazine
Isolation is a prescription for coronavirus, but a threat to addiction treatment in the Lehigh Valley The Morning Call (Pennsylvania)
With You through COVID-19: crisis and recovery We Are With You
COVID-19 et la phase de rétablissement à la pandémie pour les personnes avec des problèmes de dépendance ou en situation d’itinérance (in French only) Institut national d'excellence en santé et en services sociaux

 

Substances

Substances

Resource Organization
Getting Back on the Road Impaired Driving Risks (Infographic) Canadian Centre on Substance Use and Addiction
COVID ‐19 and alcohol in Australia: Industry changes and public health impacts Drug and Alcohol Review
COVID-19 et la phase de rétablissement à la pandémie pour les personnes avec des problèmes de dépendance ou en situation d’itinérance (in French only) Institut national d'excellence en santé et en services sociaux

 

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.